Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 21 to 30 of 112

TitlePrioritisation programmeDecisionDecision date
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]None selectedNot selected
Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years [TSID12204]None selectedNot selected
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]None selectedNot selected
Subcutaneous nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over [TSID 12178]None selectedNot selected
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106None selectedNot selected
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]None selectedNot selected
Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173]None selectedNot selected
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]None selectedNot selected
Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171]None selectedNot selected
NEMOST growing domino for Neuromuscular early onset scoliosis with Risser 0 in first surgical intentionHealthTechAwaiting decision

Results per page

  1. 10
  2. 25
  3. 50
  4. All